logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > TP 235 CAS 443104-02-7

TP 235 CAS 443104-02-7

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 443104-02-7

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
443104-02-7
Appearance::
Pale Yellow Solid
Molecular Formula::
C34H43N3O3
Molecular Weight::
541.72400
EINECS NO::
NA
MDL NO::
NA
CAS NO::
443104-02-7
Appearance::
Pale Yellow Solid
Molecular Formula::
C34H43N3O3
Molecular Weight::
541.72400
EINECS NO::
NA
MDL NO::
NA
TP 235 CAS 443104-02-7

Product Description:

Product Name: TP 235 CAS NO: 443104-02-7

 

 

Synonyms:

CDDO Imidazolide;

CDDO-Im;

(4aR,6aR,6aS,6bR,8aS,12aS,14bS)-8a-(imidazole-1-carbonyl)-4,4,6a,6b,11,11,14b-heptamethyl-3,13-dioxo-4a,5,6,6a,7,8,9,10,12,12a-decahydropicene-2-carbonitrile;

 

 

Chemical & Physical Properties:

Appearance: Pale yellow solid

Assay :≥98.0%

Boiling Point: 681.8±65.0℃(Predicted)

Density: 1.23±0.1 g/cm3 (Predicted)

PKa: 3.47±0.10 (Predicted)

 

 

CDDO Imidozolide (CDDO-Im) is a synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells. Studies show that CDDO-Im is highly active in suppressing cellular proliferation of human leukemia and breast cancer cell lines as well as being an effective therapeutic agent in the treatment of other types of cancers.

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.